WeRide Inc. — Board/Management Information 2004

Jun 21, 2004

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED 遠東生物制藥科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 399)

CHANGES IN DIRECTORSHIP

The board of directors (“Board”) of Far East Pharmaceutical Technology Company Limited (the “Company”) announces that Mr. Tso Ming Sing, Barton has tendered his resignation as executive director of the Company due to personal reasons with effect from 18 June, 2004 and remains as the general manager of the Company. Both the Board and Mr. Tso confirmed that Mr. Tso had no disagreement with the Board and Mr. Tso confirmed that he was not aware of any matters which need to be drawn to the attention of the shareholders of the Company.

As at the date of this announcement, the Board comprises of 5 executive directors, namely, Mr. Cai Chong Zhen, Mr. Chen Ching Ken, Mr. Cai Chong Yi, Mr. Chen Wei and Ms. Shen Ye, and 2 independent non-executive directors, namely, Ms. Hu Ling Po and Mr. Yu Er Feng.

By order of the Board of

Far East Pharmaceutical Technology Company Limited Mr. Cai Chong Yi Executive Director

Hong Kong, 18th June, 2004.

Please also refer to the published version of this announcement in China Daily.

1 FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED – Announcement

18th June, 2004